Colon cancer has a high rate of recurrence even with good response to modern therapies. Novel curative adjuncts are needed. Oncolytic viral therapy has shown preclinical promise against colon cancer but lacks robust efficacy in clinical trials and raises regulatory concerns without real-time tracking of viral replication. https://www.roneverhart.com/HP-EliteDisplay-S14-14-FHD-LED-Monitor-1080p-Portable-Display-60Hz-5ms-16-9-200-cd-m-700-1-USB-C-3HX46A8/